John Pappadakis
EVP Global Business Development
John Pappadakis is the Executive Vice President of Global Business Development at Clinical ink. For nearly 35 years, he has held various sales and marketing leadership roles within the pharma industry to drive commercial excellence. In his current role, he leads the global Business Development and Outcome Solutions teams and has helped define Clinical ink’s commercial, marketing, and scientific strategies. Prior to Clinical ink, John held sales leadership roles at Oracle and IMS Health, where he had responsibilities for both commercial and R&D strategies. He also played an instrumental role in assuring the launch and overall market success of over 30 drugs while working at Pfizer and Parke-Davis.
